Navigation Links
Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
Date:1/14/2011

The Case Western Reserve University/University Hospitals AIDS Clinical Trials Unit is now screening potential participants for a nationwide HIV vaccine clinical trial (HVTN505) being conducted by the HIV Vaccine Trials Network. The HIV vaccine trial is the first of its kind in Cleveland since 2003.

The trial is testing the safety and effectiveness of a combination of two HIV vaccines to see if they will stimulate an immune response to HIV or decrease the amount of virus in the blood if a person later becomes infected. Neither vaccine can cause HIV infection. The trial, which also is open in 15 other U.S. cities, is looking to enroll 1,350 gay men and transgender women. Participants must be 18-50 years old and HIV-uninfected (negative).

"Historically, vaccines have been key to ending viral epidemics," said Benigno Rodriguez, MD, an infectious disease physician at University Hospitals (UH) Case Medical Center and assistant professor of medicine at Case Western Reserve School of Medicine. "Even with good antiretroviral therapy, millions of people become newly infected each year. We cannot treat our way out of this epidemic."

"Throughout the AIDS epidemic, Greater Cleveland's gay community has consistently supported AIDS-related clinical trials. We believe that the men of Cleveland will want to stand up and learn more about HIV vaccine research. We anticipate that many will be willing to participate in this study," continued Dr. Rodriguez.

People interested in learning more about the vaccine trial should call 216-844-4444 or email info@case.edu

The vaccine trial comes to Cleveland after a year of promising developments in the worldwide search for effective new tools to help stem the AIDS epidemic, now entering its third decade. Last year, clinical trials proved some level of effectiveness for two HIV prevention strategies. The CAPRISA004 study demonstrated for the first time that a microbicide a gel used by a woman prior to sexual activity, could reduce a woman's risk of acquiring HIV. Another clinical trial showed that antiretroviral drugs used to treat people living with HIV can reduce a person's risk of acquiring HIV if used consistently prior to sexual contact.


'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Related medicine news :

1. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
2. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
3. Visionworks(R) Brings High Quality Eye Care & Eye Wear to Western PA
4. Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
5. Case Western Reserve receives nearly $8M to help providers enable adoption of EHRs in Ohio
6. ShelterBox Responds to Earthquake in Western China
7. Western Maryland to be Featured at BIO International Convention
8. UT Southwestern researchers uncover Fragile X syndrome genes role in shaping brain
9. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
10. Belly fat or hip fat -- it really is all in your genes, says UT Southwestern researcher
11. Novel anti-malarial drug candidate found by UT Southwestern researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... 29, 2017 , ... Sterling Global Products is pleased to ... biodegradable, hanging flushable wipes dispensers and/or 42 count refill packs manufactured by this ... Texas, operates more than 350 stores throughout Texas and expanding into northern Mexico ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals ... This begins with the popular ClearLungs Extra Strength formula. To ensure that the effectiveness ... in the following ways:, , Removal of the homeopathic element ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: April ... “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on her ... Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she was ...
(Date:4/28/2017)... ... 2017 , ... Children and adolescents who enter the foster ... in the general population. That’s because foster care is designed to protect children ... no fault of their own, youth who have experienced trauma often have difficulty ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
Breaking Medicine Technology: